Mission INNOCAN Pharma It is possible that we could very soon see price gains in this share that we have not seen for a long time. 100% and more would not be a surprise for me.
InnoCan Pharma* (WKN: A2PSPW) CEO Iris Bincovich has repeatedly indicated that the liposome/CBD technology is aimed at treating diseases of the central nervous system. More specifics have not been available to date. The research is being carried out in the laboratory of Professor Chezy Barenholz, winner of Israel's highest scientific award (EMET Prize - "Israeli Nobel Prize"). The Twitter message now published by Ms. Bincovich suggests that they will go into detail very soon:Mdission 100